Rheumatic Diseases and Syndromes Induced by Cancer Immunotherapy
portes grátis
Rheumatic Diseases and Syndromes Induced by Cancer Immunotherapy
A Handbook for Diagnosis and Management
Suarez-Almazor, Maria E.; Calabrese, Leonard H.
Springer Nature Switzerland AG
02/2021
363
Mole
Inglês
9783030568238
15 a 20 dias
504
Descrição não disponível.
PART 1 - INTRODUCTION.- 1. Cancer Immunology and the evolution of immunotherapy.- 2. Cancer immunotherapy: overview.- 3. Pathogenesis of immune-related adverse events.- PART 2 - IMMUNE-RELATED ADVERSE EVENTS WITH IMMUNE-CHECKPOINT INHIBITORS.- 4. Arthritis.- 5. Polymyalgia rheumatica.- 6. Myositis.- 7. Sicca syndromes.- 8. Sarcoidosis.- 9. Miscellaneous rheumatic syndromes.- 10. Non-rheumatic immune-related adverse events.- 11. Immune-related adverse events with other cancer immunotherapies.- PART 3 - CANCER IMMUNOTHERAPY IN PATIENTS WITH PRE-EXISTING RHEUMATIC DISEASES.- 12. Inflammatory arthritis.- 13. Other rheumatic autoimmune diseases.- 14. Choosing the right therapy.- 15. Risk-benefit considerations.- 16. Patient education and shared-decision making.
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
Cancer immunotherapy and rheumatic diseases;Cancer immunotherapy and arthritis;Cancer immunotherapy and myositis;Cancer immunotherapy and polymyalgia rheumatic;Cancer immunotherapy and Sjogren's syndrome;Cancer immunotherapy-induced rheumatic diseases;Immune checkpoint inhibitors (ICI);Rheumatic immune-related adverse events (irAE)
PART 1 - INTRODUCTION.- 1. Cancer Immunology and the evolution of immunotherapy.- 2. Cancer immunotherapy: overview.- 3. Pathogenesis of immune-related adverse events.- PART 2 - IMMUNE-RELATED ADVERSE EVENTS WITH IMMUNE-CHECKPOINT INHIBITORS.- 4. Arthritis.- 5. Polymyalgia rheumatica.- 6. Myositis.- 7. Sicca syndromes.- 8. Sarcoidosis.- 9. Miscellaneous rheumatic syndromes.- 10. Non-rheumatic immune-related adverse events.- 11. Immune-related adverse events with other cancer immunotherapies.- PART 3 - CANCER IMMUNOTHERAPY IN PATIENTS WITH PRE-EXISTING RHEUMATIC DISEASES.- 12. Inflammatory arthritis.- 13. Other rheumatic autoimmune diseases.- 14. Choosing the right therapy.- 15. Risk-benefit considerations.- 16. Patient education and shared-decision making.
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
Cancer immunotherapy and rheumatic diseases;Cancer immunotherapy and arthritis;Cancer immunotherapy and myositis;Cancer immunotherapy and polymyalgia rheumatic;Cancer immunotherapy and Sjogren's syndrome;Cancer immunotherapy-induced rheumatic diseases;Immune checkpoint inhibitors (ICI);Rheumatic immune-related adverse events (irAE)
